Goutham Atla is a dedicated researcher specializing in epigenetics of complex traits. They obtained their PhD from the University of Barcelona's Faculty of Medicine with affiliation to Imperial College London, during which they focused on understanding the genetic regulatory mechanisms of type 2 diabetes pathophysiology. Currently, Goutham works as a Specialist in Epigenetics at Novo Nordisk's Human Genetics Centre of Excellence in Oxford, UK, where they analyze large-scale genetic and genomic data to interpret cell-specific effects of genetic variants in transcriptional and post-transcriptional gene regulation. Their work in large pharma has involved the identification of human genetics-supported drug targets and targets for novel therapeutic modalities.